Sundahl, N., De Wolf, K., Rottey, S., Decaestecker, K., De Maeseneer, D., Meireson, A., . . . Ost, P. (2017). A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: Evaluation of safety and clinical and immunologic response. J Transl Med.
Citação norma ChicagoSundahl, Nora, et al. "A Phase I/II Trial of Fixed-dose Stereotactic Body Radiotherapy With Sequential or Concurrent Pembrolizumab in Metastatic Urothelial Carcinoma: Evaluation of Safety and Clinical and Immunologic Response." J Transl Med 2017.
ציטוט MLASundahl, Nora, et al. "A Phase I/II Trial of Fixed-dose Stereotactic Body Radiotherapy With Sequential or Concurrent Pembrolizumab in Metastatic Urothelial Carcinoma: Evaluation of Safety and Clinical and Immunologic Response." J Transl Med 2017.